BPMC May 2024 110.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:29PM EDT
| Previous close | 4.7000 |
| Open | 3.0000 |
| Bid | 1.7500 |
| Ask | 5.0000 |
| Strike | 110.00 |
| Expiry date | 2024-05-17 |
| Day's range | 2.7500 - 3.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 39 |
Insider MonkeyBlueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript
Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2024 Earnings Call Transcript May 2, 2024 Blueprint Medicines Corporation misses on earnings expectations. Reported EPS is $ EPS, expectations were $-1.64. Blueprint Medicines Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. […]
ZacksBlueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
Blueprint (BPMC) gains from better-than-expected first-quarter 2024 results, driven by robust Ayvakit sales growth. The company raises its revenue guidance for 2024.
- GuruFocus.com
Blueprint Medicines Corp (BPMC) (Q1 2024) Earnings Call Transcript Highlights: Surpassing ...
Blueprint Medicines reports robust Q1 earnings, raises EBITDA outlook, and progresses in key pipeline developments.
© 2024 Yahoo. All rights reserved.